PMDA drug package insert
ベクティビックス点滴静注100mg
PMDA Prescription drug · 武田薬品工業株式会社 · package insert Mar 25, 2026
Key facts
| Brand names | ベクティビックス点滴静注100mg, ベクティビックス点滴静注400mg |
|---|---|
| Nonproprietary names | パニツムマブ（遺伝子組換え） |
| Companies | 製造販売元／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤; ヒト型抗EGFR注1）モノクローナル抗体 注1）EGFR ： Epidermal growth factor receptor（上皮細胞増殖因子受容体） |
| Therapeutic category codes | 874291 |
| YJ codes | 4291417A1020, 4291417A2027 |
| Approval numbers | 22200AMX00307, 22300AMX00586 |
| Package insert edition | 第3版 |
| Package insert date | Mar 25, 2026 |
| PMDA document key | 400256_4291417A1020_1 |
| PMDA company code | 400256 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: